The WatchBotTM platform will address a variety of critical use cases at Coastal Waste & Recycling facilities, including ...

Bringing over 30 years of leadership in automotive software, connected vehicle systems, and digital innovation ...

SEON, the command center for fraud prevention and compliance, today announced the appointment of Angela Pierce as Chief ...

Westwood Holdings Group, Inc. (NYSE:WHG) will release its second quarter 2025 earnings after the close of the New York Stock ...

Cerro de Pasco Resources Inc. (TSXV: CDPR) (BVL: CDPR) (OTCMKTS: GPPRF) (FRA: N8HP) ('CDPR” or the 'Company”) is pleased to ...

Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting ...

Using audio narration and video recordings of lab work, PRISM builds easily shareable and repeatable experimental protocols ...

BitFuFu Inc. ('BitFuFu” or the 'Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today ...

During the year ended April 30, 2025, net cash provided by financing activities was $10.4 millionStockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cashIn May 2025, ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three ...

- Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in patients with KRASG12D-mutant pancreatic, colorectal, and ...

David Koos, the Chairman and CEO of Regen Biopharma, Inc., discussed the Company’s intention to seek Orphan Drug Designation for HemaXellerate, the Company’s proprietary aplastic anemia cell therapy ...